-+ 0.00%
-+ 0.00%
-+ 0.00%

*Pulmatrix Intends to Divest Assets Including Phase 2-Ready Acute Migraine Candidate, PUR3100, and Other Development Candidates Based on iSPERSE Technology >PULM

Dow Jones·03/21/2025 12:10:00

Please log in to view news